Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
FTK
|
James A Silas
SVP Research and Innovation |
BUY
Grant, award, or other acquisition
|
Direct | 57,803 Added 12.09% |
-
|
Mar 08
2022 |
|
FTK
|
Nicholas J. Bigney
SVP General Counsel |
BUY
Grant, award, or other acquisition
|
Direct | 57,803 Added 16.43% |
-
|
Mar 08
2022 |
|
CPS
|
Jeffrey S Edwards
Chairman and CEO |
BUY
Open market or private purchase
|
Indirect | 22,900 Added 50.0% |
$200,146
$8.74 p/Share
|
Mar 08
2022 |
|
CPS
|
Larry Ott
Officer |
BUY
Open market or private purchase
|
Direct | 1,500 Added 7.83% |
$12,315
$8.21 p/Share
|
Mar 08
2022 |
|
AZYO
|
Matthew Ferguson
CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct | 1,288 Added 13.66% |
-
|
Mar 08
2022 |
|
AZYO
|
Jerome Riebman
CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct | 782 Added 12.79% |
-
|
Mar 08
2022 |
|
AZYO
|
Ronald K. Lloyd
PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 4,072 Added 11.36% |
-
|
Mar 08
2022 |
|
AZYO
|
Darryl Roberts
EVP, OPERATIONS & PRODUCT DEV. |
BUY
Exercise of conversion of derivative security
|
Direct | 938 Added 21.98% |
-
|
Mar 08
2022 |
|
AZYO
|
Thomas Englese
CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct | 938 Added 11.99% |
-
|
Mar 08
2022 |
|
QUIK
|
Timothy Saxe
SR. VP AND CTO |
BUY
Exercise of conversion of derivative security
|
Direct | 664 Added 0.92% |
-
|
Mar 08
2022 |
|
QUIK
|
Brian C Faith
PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 1,170 Added 0.98% |
-
|
Mar 08
2022 |
|
PBHC
|
Ronald Tascarella
Retired Executive Vice Pres. |
SELL
Open market or private sale
|
Direct | 83 Reduced 0.14% |
$1,465
$17.65 p/Share
|
Mar 08
2022 |
|
JAKK
|
Lawrence I Rosen
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 5,799 Added 0.32% |
$87,971
$15.17 p/Share
|
Mar 08
2022 |
|
FCCO
|
Tanya A Butts
EVP and Senior Advisor |
SELL
Payment of exercise price or tax liability
|
Direct | 329 Reduced 5.12% |
$6,698
$20.36 p/Share
|
Mar 08
2022 |
|
FCCO
|
Brown, Robin D.
EVP, HR and Marketing |
SELL
Payment of exercise price or tax liability
|
Direct | 346 Reduced 1.77% |
$7,045
$20.36 p/Share
|
Mar 08
2022 |
|
FCCO
|
Michael C Crapps
President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 1,390 Reduced 2.01% |
$28,300
$20.36 p/Share
|
Mar 08
2022 |
|
SMTI
|
Shawn M. Bowman |
BUY
Grant, award, or other acquisition
|
Direct | 2,284 Added 10.0% |
-
|
Mar 08
2022 |
|
SMTI
|
Zachary B. Fleming
Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct | 8,831 Added 18.17% |
-
|
Mar 08
2022 |
|
SMTI
|
Rebecca E Mc Mahon
President - R&D |
BUY
Grant, award, or other acquisition
|
Direct | 2,047 Added 21.7% |
-
|
Mar 08
2022 |
|
SMTI
|
Michael D. Mc Neil
Ch. Acct. & Ch. Admin. Officer |
BUY
Grant, award, or other acquisition
|
Direct | 6,547 Added 24.32% |
-
|
Mar 08
2022 |
|
DBD
|
Jeffrey L Rutherford
EVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct | 185,383 Added 30.97% |
-
|
Mar 08
2022 |
|
DBD
|
Ulrich Naher
EVP, Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 168,246 Added 31.34% |
-
|
Mar 08
2022 |
|
DBD
|
Jonathan Leiken
EVP, CLO and Secretary |
BUY
Grant, award, or other acquisition
|
Direct | 127,864 Added 32.57% |
-
|
Mar 08
2022 |
|
DBD
|
Manish Choudhary
EVP, Software |
BUY
Grant, award, or other acquisition
|
Direct | 39,631 Added 33.02% |
-
|
Mar 08
2022 |
|
DBD
|
Elizabeth Patrick
EVP, Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct | 117,846 Added 42.88% |
-
|
Mar 08
2022 |
|
DBD
|
Olaf Robert Heyden
EVP, COO |
BUY
Grant, award, or other acquisition
|
Direct | 178,315 Added 30.81% |
-
|
Mar 08
2022 |
|
IRNT
|
Donald Closser
Chief Product Officer |
SELL
Open market or private sale
|
Direct | 128,376 Reduced 19.36% |
$532,760
$4.15 p/Share
|
Mar 08
2022 |
|
NDLS
|
Thomas B West
Chief Operating Officer |
BUY
Open market or private purchase
|
Direct | 3,000 Added 3.64% |
$17,370
$5.79 p/Share
|
Mar 08
2022 |
|
VLTA
|
Eli Aheto
Director |
BUY
Grant, award, or other acquisition
|
Direct | 23,924 Added 50.0% |
-
|
Mar 08
2022 |
|
VLTA
|
Vincent T. Cubbage
Interim CEO |
BUY
Grant, award, or other acquisition
|
Direct | 23,924 Added 2.32% |
-
|
Mar 08
2022 |
|
VLTA
|
Martin Lauber
Director |
BUY
Grant, award, or other acquisition
|
Direct | 23,924 Added 8.38% |
-
|
Mar 08
2022 |
|
VLTA
|
Katherine J Savitt
Director |
BUY
Grant, award, or other acquisition
|
Direct | 23,924 Added 50.0% |
-
|
Mar 08
2022 |
|
VLTA
|
Bonita C. Stewart
Director |
BUY
Grant, award, or other acquisition
|
Direct | 23,924 Added 50.0% |
-
|
Mar 08
2022 |
|
VLTA
|
John J. Tough
Director |
BUY
Grant, award, or other acquisition
|
Direct | 23,924 Added 50.0% |
-
|
Mar 08
2022 |
|
CPSS
|
Michael T. Lavin
President |
SELL
Open market or private sale
|
Indirect | 7,475 Reduced 2.45% |
$86,859
$11.62 p/Share
|
Mar 08
2022 |
|
ACTG
|
Richard Jay Rosenstein
Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 45,000 Added 19.0% |
-
|
Mar 08
2022 |
|
ACTG
|
Lawrence Wesley Golby
Chief Investment Officer |
BUY
Grant, award, or other acquisition
|
Direct | 100,000 Added 28.99% |
-
|
Mar 08
2022 |
|
ACTG
|
Jason W. Soncini
General Counsel |
BUY
Grant, award, or other acquisition
|
Direct | 45,000 Added 26.71% |
-
|
Mar 08
2022 |
|
ACTG
|
Marc W. Booth
Chief IP Officer |
BUY
Grant, award, or other acquisition
|
Direct | 100,000 Added 23.83% |
-
|
Mar 08
2022 |
|
VERI
|
G Louis Graziadio Iii
Director |
BUY
Open market or private purchase
|
Indirect | 1,500 Added 9.36% |
$23,175
$15.45 p/Share
|
Mar 08
2022 |
|
SKYT
|
Steve Manko
CFO |
SELL
Open market or private sale
|
Direct | 25,200 Reduced 5.02% |
$258,300
$10.25 p/Share
|
Mar 08
2022 |
|
DMRC
|
Riley Mccormack
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 20,000 Added 36.24% |
$484,800
$24.24 p/Share
|
Mar 08
2022 |
|
DMRC
|
Alicia Syrett
Director |
BUY
Open market or private purchase
|
Direct | 2,500 Added 13.26% |
$56,325
$22.53 p/Share
|
Mar 08
2022 |
|
OPRT
|
Jonathan Aaron Coblentz
CFO & Chief Admin Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 20,000 Added 22.2% |
$26,400
$1.32 p/Share
|
Mar 08
2022 |
|
LCUT
|
Daniel Siegel
President |
SELL
Payment of exercise price or tax liability
|
Direct | 475 Reduced 0.14% |
$5,790
$12.19 p/Share
|
Mar 08
2022 |
|
LCUT
|
Daniel Siegel
President |
BUY
Grant, award, or other acquisition
|
Direct | 23,236 Added 6.25% |
-
|
Mar 08
2022 |
|
LCUT
|
Robert Bruce Kay
Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 6,234 Reduced 2.08% |
$75,992
$12.19 p/Share
|
Mar 08
2022 |
|
LCUT
|
Robert Bruce Kay
Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct | 165,856 Added 29.71% |
-
|
Mar 08
2022 |
|
LCUT
|
Laurence Winoker
EVP, Treasurer, & CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 552 Reduced 0.61% |
$6,729
$12.19 p/Share
|
Mar 08
2022 |
|
LCUT
|
Laurence Winoker
EVP, Treasurer, & CFO |
BUY
Grant, award, or other acquisition
|
Direct | 12,311 Added 11.23% |
-
|
Mar 08
2022 |